Apotex is a proudly Canadian, global pharmaceutical company with a presence in India consisting of Apotex Research Private Limited (ARPL), an affiliate of Apotex that operates in Mumbai and Bangalore, Apotex Pharmachem India Pvt Ltd (APIPL) in Bangalore, and Global Business Services (GBS), Apotex’s captive service delivery organization in Mumbai. Founded in 2004, ARPL holds expertise in the development of both generic and innovative pharmaceuticals, quality and regulatory control mechanisms, manufacturing, site transfers, bio equivalence, and clinical research. ARPL's manufacturing facility in Bangalore has been designed to support an annual output capacity of over eight billion dosages. APIPL operates a fully CGMP-compliant manufacturing facility specializing in the research and development, scale-up and manufacturing of active pharmaceutical ingredients (API), and has two multi-purpose manufacturing plants and three kilo labs. GBS operates under global policies and procedures, supporting 33 business processes across 7 functions of Apotex. Committed to excellence and focused on continuous improvement, guiding GBS is its vision to be a best-in-class service delivery function. In 2022, Apotex India was awarded the 2nd Best Place to Work in India by AmbitionBox, India's largest employee choice awards and the most popular platform for company reviews.